Bioterrorism: Categories, Agents and Public Health Concerns

Most people associate terrorism with explosions or armed attacks. But one of the most feared and difficult-to-counter threats is invisible – and biological. Bioterrorism is the deliberate release of biological agents – bacteria, viruses, or toxins – to cause disease, death, or mass panic among human populations, animals, or crops. Unlike conventional weapons, biological agents can be spread silently through air, water, or food, and may not cause illness for hours or days, making early detection extremely difficult. Understanding how these agents are classified – and why each category demands a different public health response – is essential for global preparedness.

What sets bioterrorism apart from biological warfare?
The CDC classification system: Categories A, B, and C
Category A: the highest-priority threats
Anthrax: a case study in Category A threats
Category B: moderate risk, broad dissemination potential
Category C: the emerging threat horizon
Nipah virus: the Category C agent with pandemic potential
Hantavirus: a threat from rodent reservoirs
Why bioterrorism is a sustainability and public health issue
International frameworks and ongoing vigilance

What sets bioterrorism apart from biological warfare?

While biological warfare typically targets military forces and is orchestrated by states, bioterrorism is aimed at civilian populations and is intended to terrorize or manipulate governments. The agents used can be naturally occurring microorganisms or genetically modified versions engineered to be more dangerous, resistant to antibiotics, or easier to disperse. What makes bioterrorism particularly alarming is that biological agents have relatively low costs, are relatively accessible, and can be produced and delivered while avoiding detection – making them an attractive alternative to conventional weapons for bad actors. Biological toxins are especially dangerous because they can act without any incubation period, causing near-immediate harm. Unlike a military operation, bioterrorist agents are hard to restrict to specific targets, putting entire communities at risk.

The CDC classification system: Categories A, B, and C

The U.S. Centers for Disease Control and Prevention (CDC) classifies bioterrorism agents into three categories – A, B, and C – based on how easily they can be spread, the severity of illness or death they cause, and the level of public health preparedness they require. This framework is used globally as a reference for threat assessment and emergency planning.

Category A: the highest-priority threats

Category A agents pose the highest risk to public and national security. They are easy to disseminate or transmit from person to person, result in high death rates, and have the potential to cause widespread public panic and social disruption. These agents require special public health preparedness measures and significantly enhanced disease monitoring. The CDC’s Category A list includes:

Anthrax (Bacillus anthracis)
Botulism (Clostridium botulinum toxin)
Plague (Yersinia pestis)
Smallpox (variola major)
Tularemia (Francisella tularensis)
Viral hemorrhagic fevers (filoviruses and arenaviruses)

Anthrax: a case study in Category A threats

Anthrax, caused by the spore-forming bacterium Bacillus anthracis, is one of the most studied bioterrorism agents. Its first modern use in biological warfare occurred in 1916, when Nordic fighters supplied by the German General Staff deployed it against the Imperial Russian Army in Finland. Anthrax spores are particularly hazardous because they can remain dormant in the environment for decades and become lethal once they find a suitable host – through inhalation, skin contact, or ingestion.

The most high-profile modern bioterrorism event involving anthrax occurred in the weeks following the September 11, 2001 attacks in the United States. Letters laced with anthrax spores were mailed to media offices and U.S. senators, killing five people and sickening seventeen others in what became the worst biological attack in U.S. history. The fallout was enormous: decontamination of postal facilities alone cost hundreds of millions of dollars, and the attacks fundamentally transformed how the United States approaches biodefense and emergency preparedness. The anthrax attacks demonstrated a critical lesson – that even a small amount of biological agent, delivered through everyday systems like the postal service, could cause mass disruption far beyond the number of direct casualties.

Category B: moderate risk, broad dissemination potential

Category B agents are easier to disseminate than Category A agents but result in lower mortality rates. They still require specific enhancements of CDC laboratory capacity and enhanced disease monitoring. These agents can contaminate food and water supplies or be dispersed through aerosols, making them a persistent threat to public health infrastructure. Key Category B agents include:

Brucellosis (Brucella species)
Melioidosis (Burkholderia pseudomallei)
Psittacosis (Chlamydia psittaci)
Q fever (Coxiella burnetii)
Ricin toxin from Ricinus communis (castor beans)
Abrin toxin from Abrus precatorius
Staphylococcal enterotoxin B
Typhus fever (Rickettsia prowazekii)
Viral encephalitis (alphaviruses)
Water safety threats such as Vibrio cholerae and Cryptosporidium parvum

Ricin, derived from castor beans, is a particularly notable Category B toxin. Its potential as a weapon was demonstrated as recently as 2018, when a foiled plot to use ricin in an attack in Cologne, Germany highlighted the persistent interest of extremists in biological toxins. A ricin-laced letter was also sent to the U.S. President in 2020, further underlining how accessible and attractive such agents remain to would-be attackers.

Category C: the emerging threat horizon

Category C is arguably the most unsettling classification – not because these agents are currently widespread, but because of what they could become. With advances in biotechnology, Category C agents and emerging pathogens could be produced, engineered, and disseminated more easily in the future. They may not yet be fully understood by science, but they already show potential for high mortality and large-scale public health impact. The CDC’s Category C list currently includes Nipah virus, Hantavirus, tick-borne hemorrhagic fever viruses, tick-borne encephalitis virus, yellow fever, and multidrug-resistant tuberculosis (MDR-TB).

Nipah virus: the Category C agent with pandemic potential

Nipah virus (NiV) is a bat-borne zoonotic pathogen first identified in 1998 during an outbreak among pig farmers in Malaysia. The WHO estimates its case fatality rate at 40% to 75%, and there is currently no approved vaccine or specific treatment. Both the CDC and the National Institute of Allergy and Infectious Diseases (NIAID) classify Nipah as a Category C bioterrorism pathogen, and the WHO has placed it on its R&D Blueprint for priority pathogens – meaning it is considered at high risk for triggering future epidemics or pandemics. Nipah outbreaks have occurred almost annually in Bangladesh and periodically in India, including a 2026 outbreak confirmed in West Bengal.

What makes Nipah particularly concerning from a biosecurity standpoint is the combination of three risk factors: zoonotic spillover from wildlife, documented human-to-human transmission, and the complete absence of approved vaccines or targeted antivirals. These features mean that even a small outbreak can overwhelm local health systems and trigger widespread fear – exactly the kind of disruption a bioterrorist would seek.

Hantavirus: a threat from rodent reservoirs

Hantaviruses are a group of viruses carried primarily by rodents and transmitted to humans through contact with infected animal droppings, urine, or saliva. The Old World hantaviruses cause hemorrhagic fever with renal syndrome, with affected regions including China, the Korean Peninsula, and parts of Europe. The New World variant, responsible for Hantavirus Pulmonary Syndrome, has been documented in the Americas and carries a significant mortality rate. Their potential for mass spread – and the difficulty of restricting their transmission once established – places them firmly in the Category C concern zone.

Why bioterrorism is a sustainability and public health issue

Bioterrorism is not only a security concern – it sits squarely at the intersection of human health, ecological disruption, and sustainable development. The deliberate exploitation of pathogens, many of which have zoonotic origins tied to habitat destruction and wildlife trade, highlights how ecological imbalance creates new vectors for both natural outbreaks and deliberate attacks. The emergence and re-emergence of zoonotic infections like Nipah is substantially linked to deforestation, close human-wildlife contact, and socio-economic factors – the very drivers that sustainability science seeks to address.

Robust preparedness against bioterrorism depends on the same infrastructure that manages natural disease outbreaks: strong public health surveillance, rapid laboratory response, equitable access to medical countermeasures, and cross-sector coordination. Early detection and rapid investigation are the key steps in containing any bioterrorist attack, and these capacities are only as strong as the public health systems that underpin them – systems that are often most fragile in the regions most vulnerable to zoonotic spillover.

International frameworks and ongoing vigilance

The threat of bioterrorism is recognized at the highest international levels. The U.S. National Biodefense Strategy designates biological weapons as a persistent threat, and global bodies including the WHO continuously update their priority pathogen lists to reflect evolving risks. Effective biodefense requires cross-sectoral collaboration among public health agencies, law enforcement, intelligence services, and the scientific community. It also demands investment in biosurveillance, rapid diagnostics, and the development of vaccines and treatments – particularly for Category C agents where medical countermeasures remain largely absent.

The dual-use nature of biotechnology – the same tools that could help a bioterrorist can also be used to fight back – makes this field one where ethical governance and transparent international oversight are non-negotiable. As biotechnology becomes more accessible, the window for preventing misuse narrows, making preparedness today a direct investment in global security tomorrow.

What do you think? Given that many Category C bioterrorism agents like Nipah virus have natural zoonotic origins linked to ecological disruption, should global biodefense strategies focus more heavily on preventing habitat loss and reducing human-wildlife contact – not just on developing medical countermeasures? And how should countries with limited public health infrastructure close the gap in bioterrorism preparedness, when the same systems needed to detect a deliberate attack are also essential for managing natural disease outbreaks?

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

References

PDF 📄

Table of Contents

What sets bioterrorism apart from biological warfare? 🔗

The CDC classification system: Categories A, B, and C 🔗

Category A: the highest-priority threats 🔗

Anthrax: a case study in Category A threats 🔗

Category B: moderate risk, broad dissemination potential 🔗

Category C: the emerging threat horizon 🔗

Nipah virus: the Category C agent with pandemic potential 🔗

Hantavirus: a threat from rodent reservoirs 🔗

Why bioterrorism is a sustainability and public health issue 🔗

International frameworks and ongoing vigilance 🔗